A naukri.com initiative
Eu-Startups
3w
228
Danish BioTech startup Cellugy secures €8.1 million to eradicate microplastics in personal care products
- Danish biotech startup, Cellugy, has secured €8.1 million funding support to scale up production of its biofabricated cellulose-based material, EcoFLEXY, aimed at replacing harmful microplastics in personal care products.
- EcoFLEXY is designed to replace fossil-based carbomers, reducing environmental pollution and hazardous chemical use in cosmetics, while providing superior performance in beauty products.
- Microplastics from personal care items pose environmental and potential health risks, prompting the need for sustainable alternatives in the beauty industry.
- EcoFLEXY aims to prevent release of 259 tons of microplastics annually, scaling up to 1,289 tons per year by 2034, aligning with sustainability goals.
- The project responds to impending EU microplastics ban and US limitations on PFAS, addressing the industry's need for high-quality, sustainable alternatives.
- Cellugy CEO stresses the importance of delivering bio-based solutions that surpass petrochemicals in performance, scalability, and efficiency to drive industry change.
- EcoFLEXY promises superior performance, functionality, and user experience compared to traditional biobased ingredients, catering to cosmetics manufacturers' quality and sustainability demands.
- The BIOCARE4LIFE project involving specialist experts will facilitate EcoFLEXY's scale-up process through process optimization, including data management and sustainability validation.
- The €8.1 million investment will support critical scaling activities, process optimization, and commercial validation over the next four years.
- Cellugy aims to eliminate petrochemical use in the industry with revenue generation and environmental impact expected in the next three to five years, thanks to the funded scaling activities.
Read Full Article
13 Likes
For uninterrupted reading, download the app